ROLE OF CARDIAC BIOMARKERS IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY TREATED WITH CARDIAC MYOSIN INHIBITORS (CMI): A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Khan, Mohammad Ishrak [1 ]
Zahir, Raisa Subaita [1 ]
Martinez, Moises Abraham Vasquez [1 ]
Osorio, Paola A. Lecompte [1 ]
Aguilar-Gallardo, Jose S. [1 ]
Lorente-Ros, Marta [1 ]
Romeo, Francisco Jose [1 ]
机构：
[1] Icahn Sch Med Mt Sinai Morningside & West, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1323-123
引用
收藏
页码：530 / 530
页数：1
相关论文
共 50 条
  • [1] CARDIAC MYOSIN INHIBITORS IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Guida, Camila Mota
    Carvalho Ferreira, Andre Luiz
    Neves, Henrique Alexsander
    Benitez Gonzalez, Maria E.
    Lima, Ana Emanuela
    Neves, Lucca Laperriere De M.
    Junqueira De Castro, Ana Beatriz
    Vilalva, Kelvin Henrique
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 640 - 640
  • [2] Efficacy of cardiac myosin inhibitors for obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomised controlled trials
    Felix, N.
    Teixeira, L. M. F.
    Nogueira, A. K. S.
    Godoi, A. C.
    Alexandre, F. K. B.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [3] The Efficacy of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Hypertrophic Cardiomyopathy: A Meta-Analysis and Systematic Review
    Yassen, Mohammad
    Changal, Khalid
    Busken, Joshua
    Royfman, Rachel
    Schodowski, Eve
    Venkataramany, Barat
    Khouri, Samer J.
    Moukarbel, George, V
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 210 : 219 - 224
  • [4] Cardiac Myosin inhibitors in patients with Symptomatic Hypertrophic Cardiomyopathy: An updated Systematic review and Meta-analysis of randomized trials
    Prata, Alonzo
    Katsuyama, Eric
    Carolina, Ana Coan
    Fernandes, Julia
    Scardini, Pedro Gabriel
    Fukunaga, Christian
    Neto, Wilson Falco
    Pinheiro, Rafael Petri Santos
    Andrade, Naieli
    Brigido, Alexandra Regia Dantas
    CIRCULATION, 2024, 150
  • [5] Cardiac Myosin Inhibitors for Obstructive Hypertrophic Cardiomyopathy: A Meta-analysis of Randomized Placebo-Controlled Trials
    Felix, Nicole
    Teixeira, Larissa
    Nogueira, Alleh
    Godoi, Amanda
    Costa, Thomaz Alexandre
    Pirez, Jacqueline
    Kherallah, Riyad Yazan
    Serpa, Frans
    Alexandre, Felipe Kalil Beirao
    de Farias, Maria do Carmo Andrade Duarte
    Vianna Silva, Guilherme
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024,
  • [6] Cardiac Myosin Inhibitors for Managing Obstructive Hypertrophic Cardiomyopathy
    Ostrominski, John W.
    Guo, Ruby
    Elliott, Perry M.
    Ho, Carolyn Y.
    JACC-HEART FAILURE, 2023, 11 (07) : 735 - 748
  • [7] Efficacy of Mavacamten on Echocardiographic Parameters and Cardiac Biomarkers in Hypertrophic Cardiomyopathy Patients: A Systematic Review and Meta-Analysis
    Otmani, Zina
    Abdrabou, Noura
    Elsayed, Hazem Ayman
    Hindawi, Mahmoud Diaa
    Awad, Ahmed K.
    CIRCULATION, 2024, 150
  • [8] Efficacy of cardiac myosin inhibitors mavacamten and aficamten in hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomised controlled trials
    Aman, Ayesha
    Akram, Arfa
    Akram, Bisma
    Maham, Momina
    Bokhari, Masooma Zainab
    Akram, Aleena
    Akram, Sania
    Yaqub, Furqan
    OPEN HEART, 2025, 12 (01):
  • [9] Update on Cardiac Myosin Inhibitors and Potential Role in Treating Obstructive Hypertrophic Cardiomyopathy
    Litt, Michael J. J.
    Day, Sharlene M. M.
    INNOVATIONS-TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY, 2023, 18 (01) : 16 - 19
  • [10] Two cardiac myosin inhibitors in the treatment of obstructive hypertrophic cardiomyopathy
    Desai, Milind Y.
    Braunwald, Eugene
    MED, 2024, 5 (07): : 655 - 659
12345